ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. - Gross,M.L.; El-Shakmak,A.; Szabo,A.; Koch,A.; Kuhlmann,A.; Munter,L.; Amann,K. (Diabetologia, 2003)